- Home
- SACH vs CCEL Comparison
SACH vs CCEL Comparison
Compare SACH & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SACH
- CCEL
- Stock Information
- Founded
- SACH 2010
- CCEL 1989
- Country
- SACH United States
- CCEL United States
- Employees
- SACH N/A
- CCEL N/A
- Industry
- SACH Real Estate Investment Trusts
- CCEL Managed Health Care
- Sector
- SACH Real Estate
- CCEL Health Care
- Exchange
- SACH Nasdaq
- CCEL Nasdaq
- Market Cap
- SACH 46.2M
- CCEL 51.9M
- IPO Year
- SACH 2017
- CCEL 1997
- Fundamental
- Price
- SACH $0.99
- CCEL $5.12
- Analyst Decision
- SACH Hold
- CCEL Strong Buy
- Analyst Count
- SACH 3
- CCEL 1
- Target Price
- SACH $2.25
- CCEL $8.50
- AVG Volume (30 Days)
- SACH 287.2K
- CCEL 9.7K
- Earning Date
- SACH 05-01-2025
- CCEL 07-14-2025
- Dividend Yield
- SACH 18.24%
- CCEL 7.83%
- EPS Growth
- SACH N/A
- CCEL N/A
- EPS
- SACH N/A
- CCEL 0.01
- Revenue
- SACH N/A
- CCEL $32,102,750.00
- Revenue This Year
- SACH N/A
- CCEL $2.49
- Revenue Next Year
- SACH $4.52
- CCEL $0.95
- P/E Ratio
- SACH N/A
- CCEL $565.95
- Revenue Growth
- SACH N/A
- CCEL 2.33
- 52 Week Low
- SACH $0.80
- CCEL $4.75
- 52 Week High
- SACH $3.16
- CCEL $9.43
- Technical
- Relative Strength Index (RSI)
- SACH 52.18
- CCEL 48.65
- Support Level
- SACH $0.90
- CCEL $4.79
- Resistance Level
- SACH $0.98
- CCEL $5.15
- Average True Range (ATR)
- SACH 0.05
- CCEL 0.17
- MACD
- SACH 0.01
- CCEL 0.05
- Stochastic Oscillator
- SACH 93.37
- CCEL 63.79
About SACH Sachem Capital Corp.
Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.